A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

NCT06559163 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Obexelimab
DRUG: Placebo

Sponsor

Zenas BioPharma (USA), LLC